谁能从服用他汀类药物中获益，何时获益？：关于从根本上重塑我们对心血管疾病一级预防的认识。 - Suppr

Who Benefits From Taking a Statin, and When?: On Fundamentally Restructuring Our Thinking Regarding Primary Prevention of Cardiovascular Disease.

作者信息

Leening Maarten J G

机构信息

Departments of Epidemiology and Cardiology, Erasmus MC-University Medical Center Rotterdam, The Netherlands. Department of Clinical Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA.

出版信息

Circulation. 2020 Sep;142(9):838-840. doi: 10.1161/CIRCULATIONAHA.120.048340. Epub 2020 Aug 31.

DOI:10.1161/CIRCULATIONAHA.120.048340

PMID:32866062

Abstract

摘要

相似文献

Who Benefits From Taking a Statin, and When?: On Fundamentally Restructuring Our Thinking Regarding Primary Prevention of Cardiovascular Disease.

Circulation. 2020 Sep;142(9):838-840. doi: 10.1161/CIRCULATIONAHA.120.048340. Epub 2020 Aug 31.

Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.

Circulation. 2017 Nov 7;136(19):1860-1862. doi: 10.1161/CIRCULATIONAHA.117.029102.

Debate on adverse effects of statins.

Eur J Intern Med. 2014 Oct;25(8):e95. doi: 10.1016/j.ejim.2014.08.006. Epub 2014 Sep 16.

Statin Adherence and Poverty - The Wide Gap in Cardiovascular Prevention.

Cardiovasc Revasc Med. 2020 Aug;21(8):1022-1023. doi: 10.1016/j.carrev.2020.06.012. Epub 2020 Jun 10.

Real-world data show the effect of statins in primary prevention.

Eur J Prev Cardiol. 2023 Nov 30;30(17):1881-1882. doi: 10.1093/eurjpc/zwad231.

Statin therapy for primary prevention of cardiovascular disease.

JAMA. 2013 Dec 11;310(22):2451-2. doi: 10.1001/jama.2013.281348.

Summary for Patients: Benefits and Risks Associated With Statin Therapy for Primary Prevention in Old and Very Old Adults.

Ann Intern Med. 2024 Jun;177(6):I18. doi: 10.7326/P24-0001. Epub 2024 May 28.

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.

J Am Heart Assoc. 2018 May 8;7(10):e008546. doi: 10.1161/JAHA.118.008546.

Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.

Circulation. 2016 Apr 19;133(16):1574-81. doi: 10.1161/CIRCULATIONAHA.115.018383. Epub 2016 Mar 4.

[A statin pill too much].

Lakartidningen. 2011;108(43):2169-70; discussion 2170-1.

引用本文的文献

Implementation of the healthy heart tool- an algorithm with potential cardiometabolic health benefits in persons with severe mental illness.

BMC Psychiatry. 2025 Feb 25;25(1):172. doi: 10.1186/s12888-025-06578-w.

Inaccurately Reported Statin Use Affects the Assessing of Lipid Profile Measures and Their Association with Coronary Artery Disease Risk.

Clin Chem. 2024 Mar 2;70(3):528-537. doi: 10.1093/clinchem/hvad223.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Who Benefits From Taking a Statin, and When?: On Fundamentally Restructuring Our Thinking Regarding Primary Prevention of Cardiovascular Disease.

作者信息

Leening Maarten J G

机构信息

出版信息

Circulation. 2020 Sep;142(9):838-840. doi: 10.1161/CIRCULATIONAHA.120.048340. Epub 2020 Aug 31.

DOI:10.1161/CIRCULATIONAHA.120.048340

PMID:32866062

Abstract

摘要

相似文献

Who Benefits From Taking a Statin, and When?: On Fundamentally Restructuring Our Thinking Regarding Primary Prevention of Cardiovascular Disease.

Circulation. 2020 Sep;142(9):838-840. doi: 10.1161/CIRCULATIONAHA.120.048340. Epub 2020 Aug 31.

Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.

Circulation. 2017 Nov 7;136(19):1860-1862. doi: 10.1161/CIRCULATIONAHA.117.029102.

Debate on adverse effects of statins.

Eur J Intern Med. 2014 Oct;25(8):e95. doi: 10.1016/j.ejim.2014.08.006. Epub 2014 Sep 16.

Statin Adherence and Poverty - The Wide Gap in Cardiovascular Prevention.

Cardiovasc Revasc Med. 2020 Aug;21(8):1022-1023. doi: 10.1016/j.carrev.2020.06.012. Epub 2020 Jun 10.

Real-world data show the effect of statins in primary prevention.

Eur J Prev Cardiol. 2023 Nov 30;30(17):1881-1882. doi: 10.1093/eurjpc/zwad231.

Statin therapy for primary prevention of cardiovascular disease.

JAMA. 2013 Dec 11;310(22):2451-2. doi: 10.1001/jama.2013.281348.

Summary for Patients: Benefits and Risks Associated With Statin Therapy for Primary Prevention in Old and Very Old Adults.

Ann Intern Med. 2024 Jun;177(6):I18. doi: 10.7326/P24-0001. Epub 2024 May 28.

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.

J Am Heart Assoc. 2018 May 8;7(10):e008546. doi: 10.1161/JAHA.118.008546.

Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.

Circulation. 2016 Apr 19;133(16):1574-81. doi: 10.1161/CIRCULATIONAHA.115.018383. Epub 2016 Mar 4.

[A statin pill too much].

Lakartidningen. 2011;108(43):2169-70; discussion 2170-1.

引用本文的文献

Implementation of the healthy heart tool- an algorithm with potential cardiometabolic health benefits in persons with severe mental illness.

BMC Psychiatry. 2025 Feb 25;25(1):172. doi: 10.1186/s12888-025-06578-w.

Inaccurately Reported Statin Use Affects the Assessing of Lipid Profile Measures and Their Association with Coronary Artery Disease Risk.

Clin Chem. 2024 Mar 2;70(3):528-537. doi: 10.1093/clinchem/hvad223.

Who Benefits From Taking a Statin, and When?: On Fundamentally Restructuring Our Thinking Regarding Primary Prevention of Cardiovascular Disease.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Who Benefits From Taking a Statin, and When?: On Fundamentally Restructuring Our Thinking Regarding Primary Prevention of Cardiovascular Disease.

作者信息

机构信息

出版信息

相似文献

引用本文的文献